SIRTLab Corporation Appoints Michael G. Kauffman, MD, PhD, as Co-Chairman of the Board of Directors and Chief Medical Officer

/PRNewswire/ -- SIRTLab Corporation, a pioneer in the manipulation of sirtuin proteins for the treatment of severe liver diseases and longevity, today...

Related Keywords

Israel ,Harvard University ,Massachusetts ,United States ,Rehovot ,Hamerkaz ,Tel Aviv ,Michaelg Kauffman ,Hagit Ashush ,Amir Shukrun ,David Sinclair ,Chaim Cohen ,Michael Kauffman ,Boaz Misholi ,Karyopharm Therapeutics Inc ,Sirtlab Corporation ,Harvard Medical School ,Bar Ilan University ,Predix Pharmaceuticals Inc ,Johns Hopkins Medical School ,Proteolix Inc ,Source Sirtlab Corporation ,Pharmaceuticals Inc ,Onyx Pharmaceuticals Inc ,Development Program At Millennium Pharmaceuticals ,Prnewswire Sirtlab Corporation ,Bar Ilan University In Tel Aviv ,Chief Medical Officer ,Professor Haim Cohen ,Chief Scientist ,Vice President ,Chief Financial ,Chief Executive Officer ,Karyopharm Therapeutics ,Co Chairman Boaz ,Predix Pharmaceuticals ,Development Program ,Millennium Pharmaceuticals ,Millennium Predictive Medicine ,Beth Israel Hospital ,Massachusetts General ,Rehovot Science Park ,Professor David Sinclair ,Professor Cohen ,